| Literature DB >> 33296081 |
Patrick Maschmeyer1, Gitta Anne Heinz1, Christopher Mark Skopnik2, Lisanne Lutter3, Alessio Mazzoni4, Frederik Heinrich1, Sae Lim von Stuckrad5,6, Lorenz Elias Wirth1, Cam Loan Tran1, René Riedel1, Katrin Lehmann1, Imme Sakwa1, Rolando Cimaz7,8, Francesco Giudici9, Marcus Alexander Mall5,10, Philipp Enghard2, Bas Vastert3, Hyun-Dong Chang1, Pawel Durek1,11, Francesco Annunziato4, Femke van Wijk3, Andreas Radbruch1, Tilmann Kallinich1,5,10, Mir-Farzin Mashreghi1,11.
Abstract
T lymphocytes accumulate in inflamed tissues of patients with chronic inflammatory diseases (CIDs) and express pro-inflammatory cytokines upon re-stimulation in vitro. Further, a significant genetic linkage to MHC genes suggests that T lymphocytes play an important role in the pathogenesis of CIDs including juvenile idiopathic arthritis (JIA). However, the functions of T lymphocytes in established disease remain elusive. Here we dissect the transcriptional and the clonal heterogeneity of synovial T lymphocytes in JIA patients by single-cell RNA sequencing combined with T cell receptor profiling on the same cells. We identify clonally expanded subpopulations of T lymphocytes expressing genes reflecting recent activation by antigen in situ. A PD-1+ TOX+ EOMES+ population of CD4+ T lymphocytes expressed immune regulatory genes and chemoattractant genes for myeloid cells. A PD-1+ TOX+ BHLHE40+ population of CD4+ , and a mirror population of CD8+ T lymphocytes expressed genes driving inflammation, and genes supporting B lymphocyte activation in situ. This analysis points out that multiple types of T lymphocytes have to be targeted for therapeutic regeneration of tolerance in arthritis.Entities:
Keywords: BHLHE40; EOMES; PD-1; T cells; TOX; chronic inflammation; juvenile idiopathic arthritis
Year: 2021 PMID: 33296081 DOI: 10.1002/eji.202048797
Source DB: PubMed Journal: Eur J Immunol ISSN: 0014-2980 Impact factor: 5.532